𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Phase I trial of ilmofosine as a 24 hour infusion weekly

✍ Scribed by M. Mehren; B. J. Giantonio; C. McAleer; R. Schilder; J. McPhillips; P. J. O'Dwyer


Publisher
Springer US
Year
1995
Tongue
English
Weight
491 KB
Volume
13
Category
Article
ISSN
0167-6997

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


A phase I trial of continuous infusion c
✍ Marshall R. Posner; Laura Ferrari; James F. Belliveau; Francis J. Cummings; Mich πŸ“‚ Article πŸ“… 1987 πŸ› John Wiley and Sons 🌐 English βš– 427 KB πŸ‘ 2 views
A simplified regimen of weekly high dose
✍ Tsai-Shen Yang; Kuan-Cheng Hsu; Jy-Ming Chiang; Reiping Tang; Jinn-Shium Chen; C πŸ“‚ Article πŸ“… 1999 πŸ› John Wiley and Sons 🌐 English βš– 70 KB πŸ‘ 2 views

## BACKGROUND. Reports of in vitro experiments in colorectal carcinoma cells suggest that prolonged cellular exposure to 5-fluorouracil (5-FU) combined with relatively low concentrations of leucovorin (LV) provides optimal enhancement of 5-FU efficacy. In this study, a simplified regimen of weekly

Phase I clinical trial and pharmacokinet
✍ Charles L. Vogel; Elizabeth Gorowski; Enrique Davila; Mario Eisenberger; James K πŸ“‚ Article πŸ“… 1987 πŸ› Springer US 🌐 English βš– 823 KB

ICRF-187 was given to 62 evaluable patients with advanced solid tumors in a Phase I clinical trial. Weekly infusions were given in dosages ranging from 0.85 g/m2 to 7.42 g/m2 for a total of four weeks with a two week rest period between courses. Dose-limiting hematological toxicity was seen in heavi